The U.S. House of Representatives oversight panel said on Tuesday it will hold a hearing with executives from U.S. pharmacy benefit managers on the role of the firms in rising healthcare costs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,